Abstract

The amyloid β peptide (AβP) is a small fragment of the much larger, broadly distributed amyloid precursor protein (APP). Abundant AβP deposition in the brains of patients with Alzheimer's disease suggests that altered APP processing may represent a key pathogenic event. Direct protein structural analyses showed that constitutive processing in human embryonic kidney 293 cells cleaves APP in the interior of the AβP, thus preventing AβP deposition. A deficiency of this processing event may ultimately prove to be the etiological event in Alzheimer's disease that gives rise to senile plaque formation.

Keywords

Amyloid precursor proteinSenile plaquesPeptideAmyloid (mycology)Amyloid betaP3 peptideAmyloid precursor protein secretaseCleavage (geology)BETA (programming language)Alzheimer's diseaseProtein precursorBiochemistry of Alzheimer's diseaseChemistryBiologyDiseaseBiochemistryMedicinePathologyEnzymeComputer science

Affiliated Institutions

Related Publications

Publication Info

Year
1990
Type
article
Volume
248
Issue
4959
Pages
1122-1124
Citations
1389
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1389
OpenAlex

Cite This

Fred Esch, Pamela S. Keim, Eric C. Beattie et al. (1990). Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor. Science , 248 (4959) , 1122-1124. https://doi.org/10.1126/science.2111583

Identifiers

DOI
10.1126/science.2111583